Board of Regents of the University System of Georgia

Augusta, Georgia 30912

0 studies enrolling now · 1 studies all time

What they study most

Chronic Myeloid Leukemia (for Part B and C), Healthy (For Part A)

Studies at this site

• Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies — Stopped early